{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T08:06:10Z","timestamp":1791446770629,"version":"4.3.3"},"reference-count":35,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.healun.2023.01.001","type":"journal-article","created":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T20:57:57Z","timestamp":1673470677000},"page":"778-785","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Outcomes in patients with cardiac amyloidosis undergoing heart transplantation: the eurotransplant experience"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0004-4516","authenticated-orcid":false,"given":"Martin J.","family":"Kraus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline M.","family":"Smits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna L.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0538-283X","authenticated-orcid":false,"given":"Agita","family":"Strelniece","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne","family":"van Kins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8128-9659","authenticated-orcid":false,"given":"Udo","family":"Boeken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Reinecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zdenek","family":"Provaznik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Van Caenegem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0424-2424","authenticated-orcid":false,"given":"Arnaud","family":"Ancion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Berchtold-Herz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan J.A.","family":"Van Cleemput","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Haverich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guenther","family":"Laufer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Gummert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Karck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4689-5714","authenticated-orcid":false,"given":"Gregor","family":"Warnecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip W.","family":"Raake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Frey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael M.","family":"Kreusser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2023.01.001_bib0001","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1056\/NEJMra023144","article-title":"Molecular mechanisms of amyloidosis","volume":"349","author":"Merlini","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2023.01.001_bib0002","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1080\/07853890701206887","article-title":"The workings of the amyloid diseases","volume":"39","author":"Bellotti","year":"2007","journal-title":"Ann Med"},{"key":"10.1016\/j.healun.2023.01.001_bib0003","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nrcardio.2014.165","article-title":"Pathophysiology and treatment of cardiac amyloidosis","volume":"12","author":"Gertz","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.healun.2023.01.001_bib0004","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.tcm.2017.07.004","article-title":"Cardiac amyloidosis: an update on pathophysiology, diagnosis, and treatment","volume":"28","author":"Siddiqi","year":"2018","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.healun.2023.01.001_bib0005","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1146\/annurev-med-052918-020140","article-title":"Cardiac amyloidosis: overlooked, underappreciated, and treatable","volume":"71","author":"Rubin","year":"2020","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.healun.2023.01.001_bib0006","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/ajh.25149","article-title":"Immunoglobulin light chain amyloidosis: 2018 Update on diagnosis, prognosis, and treatment","volume":"93","author":"Gertz","year":"2018","journal-title":"Am J Hematol"},{"key":"10.1016\/j.healun.2023.01.001_bib0007","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2023.01.001_bib0008","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2023.01.001_bib0009","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/j.jacc.2007.08.028","article-title":"Evaluation and management of the cardiac amyloidosis","volume":"50","author":"Selvanayagam","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2023.01.001_bib0010","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13473","article-title":"Initial experience with percutaneous mitral valve repair in patients with cardiac amyloidosis","volume":"51","author":"Volz","year":"2021","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.healun.2023.01.001_bib0011","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.healun.2013.01.987","article-title":"Left ventricular device implantation for advanced cardiac amyloidosis","volume":"32","author":"Swiecicki","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2023.01.001_bib0012","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/jce.12123","article-title":"Implantable cardioverter defibrillators in patients with cardiac amyloidosis","volume":"24","author":"Lin","year":"2013","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.healun.2023.01.001_bib0013","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10741-017-9601-z","article-title":"Heart transplantation in cardiac amyloidosis","volume":"22","author":"Sousa","year":"2017","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.healun.2023.01.001_bib0014","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.healun.2017.11.015","article-title":"Improved outcomes after heart transplantation for cardiac amyloidosis in the modern era","volume":"37","author":"Kristen","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2023.01.001_bib0015","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.healun.2014.09.006","article-title":"Changing outcomes after heart transplantation in patients with amyloid cardiomyopathy","volume":"34","author":"Davis","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2023.01.001_bib0016","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.healun.2013.09.004","article-title":"Predictors of survival to orthotopic heart transplant in patients with light chain amyloidosis","volume":"33","author":"Gray Gilstrap","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2023.01.001_bib0017","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14308","article-title":"Intermediate-term outcomes of heart transplantation for cardiac amyloidosis in the current era","volume":"35","author":"Vaidya","year":"2021","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2023.01.001_bib0018","doi-asserted-by":"crossref","unstructured":"CD Barrett, KM Alexander, H Zhao, et al., Outcomes in patients with cardiac amyloidosis undergoing heart transplantation, JACC Heart Fail, 8, 461\u2013468, 2020.","DOI":"10.1016\/j.jchf.2019.12.013"},{"key":"10.1016\/j.healun.2023.01.001_bib0019","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.transproceed.2020.08.020","article-title":"Outcomes of heart transplantation in cardiac amyloidosis patients: a single center experience","volume":"53","author":"Chen","year":"2021","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2023.01.001_bib0020","unstructured":"Smits J. Eurotransplant Manual\u00a9, Chapter 6, p. 18, 2021."},{"key":"10.1016\/j.healun.2023.01.001_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.healun.2015.10.023","article-title":"The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: a 10-year update","volume":"35","author":"Mehra","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2023.01.001_bib0022","article-title":"Declaration of Helsinki World Medical Association declaration of Helsinki","volume":"79","year":"2013","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.healun.2023.01.001_bib0023","unstructured":"ISHLT Board. International Society for Heart and Lung Transplantation Statement on Transplant Ethics. 2014."},{"key":"10.1016\/j.healun.2023.01.001_bib0024","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1161\/CIR.0000000000000792","article-title":"Cardiac amyloidosis: evolving diagnosis and management: a scientific statement from the American Heart Association","volume":"142","author":"Kittleson","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2023.01.001_bib0025","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/s00392-019-01559-y","article-title":"A novel risk score to predict survival in advanced heart failure due to cardiac amyloidosis","volume":"109","author":"Kreusser","year":"2020","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.healun.2023.01.001_bib0026","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1200\/JCO.2004.03.029","article-title":"Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis","volume":"22","author":"Dispenzieri","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.healun.2023.01.001_bib0027","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jacc.2016.06.033","article-title":"Natural history of wild-type transthyretin cardiac amyloidosis and risk stratification using a novel staging system","volume":"68","author":"Grogan","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2023.01.001_bib0028","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1093\/eurheartj\/ehx589","article-title":"A new staging system for cardiac transthyretin amyloidosis","volume":"39","author":"Gillmore","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.healun.2023.01.001_bib0029","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.20381","article-title":"Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis","author":"Gertz","year":"2005","journal-title":"Am J Hematol"},{"key":"10.1016\/j.healun.2023.01.001_bib0030","unstructured":"ISHLT. Focus theme:\u00a0trends in recipient characteristics and impact on outcomes. 2021."},{"key":"10.1016\/j.healun.2023.01.001_bib0031","unstructured":"The International Society of Heart and Lung Transplantation. ISHLT transplant registry quarterly reports for heart in Europe. 2018."},{"key":"10.1016\/j.healun.2023.01.001_bib0032","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1182\/blood.2019003633","article-title":"Daratumumab for systemic AL amyloidosis: prognostic factors and adverse outcome with nephrotic-range albuminuria","volume":"135","author":"Kimmich","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.healun.2023.01.001_bib0033","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1182\/blood-2012-12-473066","article-title":"A European collaborative study of treatment outcomes in 346 patients with cardiac stage III AL amyloidosis","volume":"121","author":"Wechalekar","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.healun.2023.01.001_bib0034","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3390\/nu9080829","article-title":"Evaluation of blood biomarkers associated with risk of malnutrition in older adults: a systematic review and meta-analysis","volume":"9","author":"Zhang","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.healun.2023.01.001_bib0035","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1161\/01.HYP.0000173433.67426.9b","article-title":"Blood pressure in adulthood and life expectancy with cardiovascular disease in men and women: life course analysis","volume":"46","author":"Franco","year":"2005","journal-title":"Hypertension"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249823000013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249823000013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:47:27Z","timestamp":1760950047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249823000013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S1053249823000013"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2023.01.001","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes in patients with cardiac amyloidosis undergoing heart transplantation: the eurotransplant experience","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2023.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 International Society for Heart and Lung Transplantation. All rights reserved.","name":"copyright","label":"Copyright"}]}}